FORINGEN
RESEARCH NETWORK FOR INFECTOGENOMICS
Diagnostics and Therapeutics
One main focus of the cooperation network lies upon the development of faster and more specific diagnostic methods. An early and reliable identification of the infectious agent is a prerequisite to estimate its pathogentic potential and to initiate an effective therapy. Additionally, the scientists of FORINGEN work to establish novel testing methods for antibiotics and to develop alternative therapeutic strategies. Thereby FORINGEN concentrates on pathogenic bacteria of the intestine, staphylococci (severe infections of wounds and sepsis, food poisoning), borrelia (Lyme disease), pseudomonas infections (chronic pneumonia in cystic fibrosis patients), Helicobacter pylori (gastritis, peptic ulcer) and HIV (AIDS)
Projects
-
DT-1 Improvement of a DNA array for diagnostics of clinically relevant enterobacteria
more -
DT-3 H. pylori pathodiagnostics
more -
DT-4 Genome-based identification of targets specific for bovine Staphylococcus aureus isolates
more -
DT-5 Development of a Microsphere based multiplex serology for differential diagnosis in reactive arthritis and lyme arthritis.
more -
DT-6 Antibiotic resistance of Pseudomonas aeruginosa from Cystic Fibrosis patients
more -
DT-8 HIV-1 Vpr as a target for antiviral therapy
more